LAUREN NIX: Open Payments
NPI 1932807187 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,081 in 104 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $79 · 2025 $2,081
Food & beverage: $2,081
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $326 |
| Lilly USA, LLC | 16 | $310 |
| ABBVIE INC. | 11 | $295 |
| AstraZeneca Pharmaceuticals LP | 4 | $203 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $174 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $160 |
| Novartis Pharmaceuticals Corporation | 6 | $140 |
| Dexcom, Inc. | 3 | $68 |
| Exact Sciences Corporation | 4 | $67 |
| PFIZER INC. | 4 | $62 |
Products named: Kerendia, BREZTRI, QULIPTA, XIFAXAN, Wegovy, LEQVIO, MOUNJARO, ZEPBOUND.
Industry payments across SC — which companies pay providers there.
